Article
Monitoring of Response and Resistance in Plasma of EGFR-Mutant Lung Cancer Using Droplet Digital PCR.
Methods in molecular biology (Clifton, N.J.) - 1 Jan 2018
Kuang Yanan, O'Connell Allison, Sacher Adrian G, Feeney Nora, Alden Ryan S, Oxnard Geoffrey R, Paweletz Cloud P
Abstract excerpt
The identification of oncogenic driver mutations has led to the rapid rise of genotype-directed treatments. However, genetic analysis of tumors remains cumbersome and a morbid experience for patients. Noninvasive assessment of tumor genotype, so-called "liquid biopsy," such as plasma genotyping represents a potentially transformative tool. Here we describe a genotyping protocol of cell-free plasma DNA (cfDNA)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
